Where the money goes
We are transparent: we show figures and spending by category; we do not detail invoices or personal data.
This is the breakdown, by category, of what the money can go to, in whatever order is needed.
Campaign status
Raised €98,482 on GoFundMe
2,355 donorsOfficial campaign
My official fundraiser is this one:
gofundme.com/f/biopsia-molecular-que-puede-cambiar-su-tratamiento (opens in a new tab)If you see any other campaign, fundraiser or initiative in my name, I didn't create it and I don't manage it.
Expense report · 30 September 2026
Where the money has gone
Rebuilt transaction by transaction from the bank statements, with figures as of 30 September 2026.
The amount raised on GoFundMe is the gross figure, live; this report shows what has been spent and what is available as of its cutoff date.
- Travel, meals and transport€13,571.66
- AI and analysis tools€10,249.37
- Diagnostics and samples€9,286.79
- Gift tax (assessed and deferred)€6,385.48
- Equipment, monitoring and infrastructure€2,523.53
- Shipping samples to the lab€2,230.70
- Legal team€1,573.00
- Outreach and communications€1,472.28
- Medication and supportive care€896.16
- Operations€882.19
- Total spent and committed€49,071.16
Still available
Estimated, net of the pending gift tax. It does not come from subtracting what was spent from what was raised: it starts from what there was as of 30 September 2026.
€9,829.47
Funding in phases
The campaign is not a single stretch: each phase unlocks the next clinical step. The first one is done; the rest are funded from what remains.
- 01
Phase 1 · Rebiopsy and immediate analysis
Bone biopsy in Zürich, done in July 2026. Spent as of 19 August 2026: €8,051.29, including tumor genomic sequencing and imaging shipping. Analysis of the tissue is still under way.
- 02
Phase 2 · Preservation and tissue banking
Freezing, OCT and live tissue stored for future analysis without another biopsy.
- 03
Phase 3 · Treatment and monitoring
International second opinions, N-of-1 trial and monitoring as biology confirms.
What the rebiopsy costs
The centrepiece of the campaign was a single bone biopsy, done in July 2026 in Zürich: everything science allows today is extracted from it, and the rest is preserved so it can be analysed for more than 10 years.
Spent as of 19 August 2026
€8,051.29
Biopsy in Zürich (€2,983.63), tumor genomic sequencing (€4,616.93), and medical imaging storage and shipping (€450.73).
Still to come
To be determined
Tissue preservation and the analyses still pending on the sample. The figures will be added to their category at each cutoff.
One procedure, not several: each preserved format avoids having to biopsy again in the future.
These are no longer estimates: they are actual spending, rebuilt from the bank statements. They stand as of 19 August 2026; “Diagnostics and samples” in the report above runs to 30 September 2026 and includes other tests, which is why it adds up to more.
The money raised covers, in whatever order is needed:
- Medical and care expenses related to the case.
- Diagnostic, follow-up and re-evaluation tests.
- Consultations with specialists and second opinions.
- Medication and treatments not fully or partially covered.
- Medical supplies and health support products.
- Travel, accommodation and meals tied to medical visits.
- AI tools used to analyze the case. It is one of the largest expenses: all the work is supported by AI.
- Processing, management and clinical documentation costs.
- Outreach, communication and campaign support.
- Professional support for organizing the crowdfunding.
- Platform fees, payment gateways and administrative costs.
- Any other medical, care or logistical need arising from the case.
Frequently asked questions
How do I know the money goes to this?
What if more is raised than expected?
Is donating safe? Is there a receipt?
Can I help without donating money?
Have another question or want a receipt? Get in touch.
Figures as of 30 September 2026.